Top Markets
Coin of the day
Pharmosa Biopharm Inc. Pharmosa Biopharm Inc.

Pharmosa Biopharm Inc.

6875
株式のランク #20403
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
株価
$1.02
時価総額
$131.45M
変化(1日)
-0.62%
変化(1年)
-37.92%
TW
取引 Pharmosa Biopharm Inc. (6875)

カテゴリー

Pharmosa Biopharm Inc.(6875)の配当利回りの履歴
Pharmosa Biopharm Inc.(銘柄コード: 6875)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Pharmosa Biopharm Inc.(6875)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)